Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Multiple Myeloma 15Leukemia, Lymphocytic, Chronic, B-Cell 10Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 7Lymphoma, Non-Hodgkin 6Burkitt Lymphoma 6Lymphoma, Mantle-Cell 5Lymphoma, B-Cell, Marginal Zone 5Lymphoma 5Astrocytoma 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Myelodysplastic Syndromes 3Lymphoma, T-Cell, Cutaneous 3Leukemia, Myelomonocytic, Chronic 3Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Acute 3Hematologic Diseases 3Waldenstrom Macroglobulinemia 2Uveal Melanoma 2Smoldering Multiple Myeloma 2Sezary Syndrome 2Optic Nerve Glioma 2Oligodendroglioma 2Mycosis Fungoides 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Promyelocytic, Acute 2

Interventions

sargramostim 1fludarabine phosphate 1bryostatin 1 1alvocidib 1Vitamin E 1Topotecan 1Peripheral Blood Stem Cell Transplantation 1Lenalidomide 1Isotretinoin 1Granulocyte-Macrophage Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Cytarabine 1Cyclosporine 1Busulfan 1Bryostatins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Thrombocytopenia × Lenalidomide × Clear all
NCT00735930 2015-04-02

Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

National Cancer Institute (NCI)

Phase 1 Completed
39 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡